Sponsor Pipeline

Italfarmaco Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
3
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06093672 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With… Polycythemia Vera Recruiting
NCT05933057 Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne… Duchenne Muscular Dystrophy Recruiting
Phase 2/3
NCT03373968 Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study Duchenne Muscular Dystrophy Recruiting
Phase 2
NCT06769633 Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to… Duchenne Muscular Dystrophy Recruiting
NCT01761968 Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic… Chronic Myeloproliferative Neoplasms Active, Not Recruiting
Disease Areas
Duchenne Muscular Dystrophy (3) Myelofibrosis (1)
Get alerts when Italfarmaco's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free